SOTERA HEALTH COMPANY Derivative Liability, Fair Value, Gross Liability
SOTERA HEALTH COMPANY (SHC) had Derivative Liability, Fair Value, Gross Liability of $3.93 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Offsetting
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2026-08-06
- 2026-06-30: Derivative Liability, Fair Value, Gross Liability $3.93M.
- 2026-03-31: Derivative Liability, Fair Value, Gross Liability $4.08M.
- 2025-12-31: Derivative Liability, Fair Value, Gross Liability $4.22M.
- 2025-06-30: Derivative Liability, Fair Value, Gross Liability $3.19M.
| Period end | Derivative Liability, Fair Value, Gross Liability |
|---|---|
| 2026-06-30 | $3.93M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $4.08M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $4.22M 10-Q · filed 2026-08-06 |
| 2025-06-30 | $3.19M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $7.15M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $4.30M 10-K · filed 2026-02-24 |
| 2024-06-30 | $2.52M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $2.70M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $414.00K 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.63M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.93M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $3.78M 10-K · filed 2024-02-27 |
| 2022-03-31 | $308.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |